1620 Investment Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

1620 Investment Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$535	Hold
2024 Q3	$1.76K	Hold
2024 Q2	$1.17K	Buy